One just might think that when one company has a virtual lock on any market they would be on easy street. We don’t think Google worries much about other internet search engines or that Amazon worries all that much about other online merchants. And to be honest we’re not sure that Medtronic (NYSE: MDT) is all that worried about other insulin pump companies. But maybe they should be.
Yes, we know that with Animas going off the market the company will command a market share of nearly 80%+. We also know that Tandem (NASDAQ: TNDM), no matter what . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.